Endometriosis affects approximately 10 percent of reproductive aged women worldwide, yet diagnosis is frequently delayed by years, with estimates varying widely across healthcare settings and geographies.1,2 Evidence identifies recurring barriers including normalization and stigmatization of menstrual pain, patient-reported shame or fear when discussing symptoms, inadequate early pain management, and structural health system constraints.1 For obstetrician–gynecologists and primary care clinicians alike, these factors influence not only time to diagnosis but also long-term treatment persistence and outcomes.
Enhancing care requires interventions at both the system and clinician level. Educational initiatives for healthcare professionals and broader awareness efforts can improve recognition of endometriosis and reduce normalization of severe menstrual pain.3 Integrating focused training into medical education may enhance early diagnostic vigilance. Interdisciplinary and multidisciplinary care models, guided by standardized protocols, support coordinated management that addresses medical, psychosocial, and functional aspects of disease.3 Within clinical encounters, patient-centered communication is essential. Establishing a consistent gynecologic contact, allowing adequate visit time, practicing active listening, and directly acknowledging pain can reduce fear and strengthen the therapeutic alliance.3 Individualized treatment plans that reflect each patient’s priorities and circumstances further promote engagement. Emerging evidence also supports structured digital health programs combining evidence-based education, cognitive behavioral strategies, and longitudinal quality-of-life monitoring. In one prospective study, participation in such a program was associated with reductions in global symptom burden, anxiety, depression, neuropathic pain, and abdominal bloating, along with measurable improvements in quality of life and disease-related knowledge compared with controls.3
For patients initiating or escalating pharmacologic therapy, aligning expectations with anticipated outcomes from the outset is critical to sustaining engagement and avoiding early discontinuation.4 Clinicians can frame improvements in pain and changes in menstrual bleeding as expected therapeutic effects rather than unexpected side effects. Emphasizing meaningful improvement in pain and function, rather than complete symptom resolution, supports realistic goal setting and patient-centered care. This approach aligns with updated guidance from the American College of Obstetricians & Gynecologists (ACOG), which highlights the value of clinical diagnosis, empiric medical management, and individualized treatment planning to improve quality of life and reduce delays in care.2 Practical considerations such as prior authorization requirements or out-of-pocket costs can be addressed proactively. Documentation of prior nonsteroidal anti-inflammatory drug (NSAID) or hormonal therapy use, early coordination with specialty pharmacies, and use of patient assistance resources can facilitate timely initiation and continuation of therapy, helping patients achieve the intended clinical benefits.
Take our endometriosis quiz to see how your knowledge compares to your peers.
